Back to Search
HERBERT BARAF, M.D.
M.D.
Rheumatology Physician
NPI: 1063411494Individual
Specialties, Licenses & Credentials
Research & Publications (7)
Resolution of gouty tophi after twelve weeks of pegloticase treatment.
PMID 18975338·Arthritis Rheum·2008
5-case
Efficacy of the newest COX-2 selective inhibitors in rheumatic disease.
PMID 17691996·Curr Pharm Des·2007
6-review
Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial.
PMID 17304660·J Rheumatol·2007
4-observational
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
PMID 18759308·Arthritis Rheum·2008
3-trial
A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout.
PMID 18055475·Ann Rheum Dis·2008
8-other
Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
PMID 15818702·Arthritis Rheum·2005
3-trial
Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
PMID 15086644·J Am Geriatr Soc·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2730 UNIVERSITY BLVD W, SUITE 310
WHEATON, MD 20902 - Phone
- (301) 942-7600
Quick Facts
- NPI
- 1063411494
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile